Contract Pharma

Breaking News | Collaborations & Alliances

Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients

Cryoport will provide tracking and proactive management for the therapies.

06.22.21

Patients as Partners in Clincial Trials

...

02.17.21

Drug Delivery | Injectables

Self-Medication: Flexibility for Patients and Drug Manufacturers

Bringing together self-medication with auto-injectors and sustainable secondary packaging.

Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients

ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.

Contract Pharma Staff 10.16.20

Breaking News | Collaborations & Alliances | Industry News

Ethypharm and RSSL Fast-Track Medicine for COVID-19 Patients

Collaborate to accelerate the manufacture and batch release of fentanyl injection

Contract Pharma Staff 06.04.20

Toronto centre solving cell manufacturing challenges to benefit patients and global industry

CCRM and Cytiva, formerly part of GE Healthcare Life Sciences, renew collaboration agreement for Centre for Advanced Therapeutic Cell Technologies

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Lilly, AbCellera Dose First Patients with COVID-19 Antibody

Phase 1 study of LY-CoV555 is the world's first study of a potential antibody treatment designed to fight COVID-19

Contract Pharma Staff 06.01.20

Breaking News | Drug Development | Trials & Filings

CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19

Will compare pacritinib plus standard of care versus placebo plus standard of care in 358 patients with severe COVID-19.

Contract Pharma Staff 04.27.20

Breaking News | Industry News

FDA COVID-19 Update

FDA issues a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine

Contract Pharma Staff 04.27.20

Breaking News | Drug Development | Industry News

Santhera, CSHL to Investigate Lonodelestat in COVID-19-related ARDS

Lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase (hNE), has potential as a therapeutic intervention for COVID-19-related ARDS.

Contract Pharma Staff 04.27.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings

Regeneron, Sanofi Release Preliminary Phase II Kevzara Results in COVID-19

Kevzara rapidly lowered C-reactive protein (CRP), a key marker of inflammation, meeting the primary endpoint.

Contract Pharma Staff 04.27.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Cytovance and Akshaya Enter Vaccine Collaboration

Partnership to focus on therapeutics for treatment of coronavirus and hepatitis B virus infections

Contract Pharma Staff 04.24.20

Breaking News | Collaborations & Alliances | Industry News

CMIC Supports Avigan Production for Potential COVID-19 Treatment

Includes clinical trials and manufacturing of influenza antiviral drug for COVID-19 patients

Contract Pharma Staff 04.24.20

Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News

Samsung Biologics, ImmuneOncia Reach Regulatory Milestone

Development and manufacturing agreement accomplishes IND clearance of IMC-002 (anti-CD47 antibody)

Contract Pharma Staff 04.24.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Trials & Filings

Theravance Initiates Study in ALI caused by COVID-19

TD-0903 has potential to inhibit cytokine storm associated with ALI and prevent progression to Acute Respiratory Distress Syndrome

04.23.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

ProThera, Takeda Enter Anti-Inflammatory Alliance

To develop a novel plasma-derived Inter-alpha Inhibitor Proteins therapy for the treatment of acute inflammatory conditions

Contract Pharma Staff 04.23.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings

Novartis’ Kymriah Gets RMAT Designation

Investigational new indication to treat patients with relapsed or refractory follicular lymphoma

Contract Pharma Staff 04.22.20

Breaking News | Drug Development | Industry News

AskBio Acquires BrainVectis

Expands clinical pipeline for neurodegenerative diseases with Huntington’s disease gene therapy candidate

Contract Pharma Staff 04.22.20

Breaking News | Drug Development | Industry News

Pharnext, UHI to Evaluate Repurposed Drugs Against COVID-19

Aims to rapidly test several approved drugs as potential candidates for fighting COVID-19 using big data and artificial intelligence

Contract Pharma Staff 04.22.20

New iPSC Master Cell Banks to Accelerate Development of Novel Cell Therapies

panCELLa and CCRM collaborate to benefit academia and industry

Breaking News | Promotions & Moves

ADC Therapeutics Appoints Jennifer Creel as CFO

Former Celgene executive brings deep oncology-focused financial expertise

Contract Pharma Staff 04.21.20

Drug Development | GMPs/GCPs | Regulatory Affairs

FDA’s Emergency Use Authorizations

Aggressive Action Taken to Combat COVID-19

Chad Landmon and Drew Hillier, Axinn, Veltrop & Harkrider LLP 04.20.20

Breaking News | Trials & Filings

Oral Anti-Viral for Covid-19 Filed under FDA’s CTAP

BioSig’s Vicromax is an orally administered drug that could be delivered to patients during all stages of Covid-19

Contract Pharma Staff 04.20.20

Breaking News | Trials & Filings

4D Pharma Begins Phase II COVID-19 Study

MRx-4DP0004, an immunomodulatory therapy, has shown potential to down-regulate hyper-inflammatory response while maintaining anti-viral response

Contract Pharma Staff 04.20.20

Breaking News | Industry News

FDA COVID-19 Update

Public-private partnership with the FDA and others aims to speed the development of COVID-19 vaccine and treatment options.

Contract Pharma Staff 04.20.20

APIs | Breaking News | Industry News

Wavelength Ups API Production for Essential Respiratory Meds

Products in demand due to coronavirus pandemic include Midazolam, Cisatracurium, and Rocuronium.

Contract Pharma Staff 04.20.20

Quality-by-Design Approach to Manufacturing Cell and Gene Therapies

...

Breaking News | Collaborations & Alliances | Industry News

Kaneka to Supply API for Fujifilm’s Avigan Tablet

Production of Avigan being ramped up for COVID-19 patients

Contract Pharma Staff 04.17.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News

AzurRx, Delpharm Enter Manufacturing Agreement

For the clinical drug product supply of MS1819 therapy for exocrine pancreatic insufficiency

Contract Pharma Staff 04.17.20

Breaking News | Collaborations & Alliances | Industry News

Evotec, leon-nanodrugs Enter Nanomedicine Pact

Evotec makes strategic investment in leon by leading the company's Series B funding round

Contract Pharma Staff 04.17.20

Breaking News | Industry News

Eagle Pharma’s Drug Shows Antiviral Activity Against COVID-19

IND submitted to FDA for clinical study at Hackensack University Medical Center to evaluate Ryanodex for treatment of COVID-19 patients

Contract Pharma Staff 04.17.20

Breaking News | Clinical Trials | Industry News

Octapharma Supports New COVID-19 Trial

Aims to assess if Intravenous Immunoglobulin (IVIG) can halt coronavirus progression to respiratory failure

Contract Pharma Staff 04.16.20

Breaking News | Clinical Trials | CRO News | Drug Development

PPD’s AES Biz Launches Patient-Transfer Program

Supports clinical trial continuity for biopharma companies during COVID-19 pandemic by transferring clinical trial patients to AES’ dedicated research sites

Contract Pharma Staff 04.16.20

Clinical Trials | Drug Development

How to Design Trials to be More Patient-Centered

Three lessons learned and how pharma can use validated measures and strategies to engage patients at every stage in the drug development lifecycle.

Jean Paty, Vice President, Patient Centered Sciences, IQVIA, Matthew Reaney, Senior Principal, Patient Centered Sciences, IQVIA 04.16.20

Bio News | Breaking News | Industry News | Inspections

WuXi Biologics Passes EMA GMP Inspection

Suzhou site clears regulatory hurdle with not critical findings

Contract Pharma Staff 04.15.20

Breaking News | Industry News

Fujifilm Boosts Production of Avigan Tablet for COVID-19

Expands manufacturing capacity at Fujifilm Toyama Chemical to increase production of its influenza antiviral drug

Contract Pharma Staff 04.15.20

Breaking News | Industry News

MedPharm Helps Fight COVID-19 Outbreak

Donates hand sanitizer for healthcare providers and other essential workers

Contract Pharma Staff 04.15.20

Breaking News | Industry News | Laboratory Testing

Abbott Launches Third COVID-19 Test

To distribute 4 million tests in April, ramping to 20 million in the U.S. per month in June and beyond

Contract Pharma Staff 04.15.20

Breaking News | Industry News

Centogene Opening Lab to Increase COVID-19 Testing

Acquiring former laboratory facilities and equipment of Provecs Medical GmbH in Hamburg, Germany

Contract Pharma Staff 04.15.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

Jenner Institute, MilliporeSigma to Scale Up Covid-19 Vax Production

Develops a rapid, scalable platform following good manufacturing practices and using disposable technologies.

Contract Pharma Staff 04.14.20

CytoSorbents Gets EUA for Blood Purification Technology

CytoSorb can be used treat cytokine storm and deadly inflammation in critically-ill COVID-19 patients

Contract Pharma Staff 04.13.20

FDA COVID-19 Update

Issues EUA for blood purification system to treat COVID-19 patients

Contract Pharma Staff 04.13.20

Breaking News | Clinical Trials | Drug Development | Industry News

Lilly, NIAID to Study Baricitinib in COVID-19

Baricitinib's anti-inflammatory activity has been hypothesized to have a potential benefit in COVID-19

Contract Pharma Staff 04.13.20

Clinical Trials | Drug Development

Gilead’s Remdesivir Shows Promise in Severe COVID-19 Cohort

Early analysis shows clinical improvement was observed in 36 of 53 patients, or 68%

Contract Pharma Staff 04.13.20

Drug Development | R&D

COVID-19 and the Importance of Combating Antimicrobial Resistance

Dr. Frank of Working to Fight AMR discusses the global COVID-19 pandemic and the critical need to address the public health crisis of Antimicrobial Resistance

Online Exclusives Kristin Brooks, Contract Pharma 04.13.20

Breaking News | Facilities | Industry News